Immuneering-logo (1).png
Immuneering Announces Participation in February Investor Conferences
February 01, 2024 08:00 ET | Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024 08:30 ET | Entera Bio Ltd.
JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...
Ion Beam Facility: Then
APTIM Selected by U.S. Department of Energy to Decommission Ion Beam Facility
August 15, 2023 08:00 ET | APTIM
Baton Rouge, La., Aug. 15, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Energy (DOE) has selected APTIM to deactivate, decommission, and remove (DD&R) the Ion Beam Facility (IBF), a former...
Oppenheimer headshot from Newsreel clip_HearstNews_UCLA_2
Historic Newsreel Clip: Oppenheimer Issues Warning
July 21, 2023 22:45 ET | UCLA Film & Television Archive
Los Angeles, CA, July 21, 2023 (GLOBE NEWSWIRE) -- Clip from Oct. 26, 1945; 50 seconds: ATOM BOMB SCIENTIST WARNS AMERICA OF DANGERS AHEAD! Research chief of atomic project, Dr. J. Robert...
Creative Mammals Revealed as Animation Studio Behind NBC News Studios' ‘To End All War: Oppenheimer & The Atomic Bomb’
July 07, 2023 10:00 ET | Creative Mammals
Film airs July 9th at 10pm ET on MSNBC; streaming on Peacock Watch the official trailer here ATLANTA, July 07, 2023 (GLOBE NEWSWIRE) -- Creative Mammals is proud to announce its first...
H&R Block to Participate in the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference
May 30, 2023 16:35 ET | HRB Tax Group, Inc.
KANSAS CITY, Mo., May 30, 2023 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that Jeff Jones, President and Chief Executive Officer, and Tony Bowen, Chief...
2019 logo_150x35_jpg.jpg
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 14, 2023 08:30 ET | Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023 07:00 ET | Synlogic, Inc.
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:30 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
Fortress Biotech to Participate in Two March 2023 Investor Conferences
March 07, 2023 08:00 ET | Fortress Biotech, Inc.
MIAMI, March 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing...